Max Planck Institute of Psychiatry, Kraepelinstr. 2, 80804, Munich, Germany.
Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):167-72. doi: 10.1007/s00406-011-0216-4. Epub 2011 May 8.
Recent findings in the literature suggest a relation between histidine triad nucleotide-binding protein-1 (HINT1) and psychiatric disorders such as major depression, anxiety, and schizophrenia, although its physiological roles are not completely comprehended. Using Western blot, we compared HINT1 protein expression in the postmortem dorsolateral prefrontal cortex and thalamus of schizophrenia patients and healthy controls for contributing to elucidate the role of HINT1 in schizophrenia pathophysiology. HINT1 was found to be downregulated in the dorsolateral prefrontal cortex and upregulated in the thalamus. Our results combined to previous studies in human samples and preclinical models support the notion that HINT1 must be more explored as a potential target for psychiatric disorders.
最近的文献研究表明,组氨酸三联核苷酸结合蛋白-1(HINT1)与精神疾病如重度抑郁症、焦虑症和精神分裂症之间存在关联,尽管其生理作用尚未完全理解。本研究使用 Western blot 技术比较了精神分裂症患者和健康对照者死后外侧前额叶皮层和丘脑的 HINT1 蛋白表达,旨在探讨 HINT1 在精神分裂症发病机制中的作用。结果发现,HINT1 在外侧前额叶皮层下调,在丘脑上调。我们的研究结果结合前人在人类样本和临床前模型中的研究结果,支持这样一种观点,即 HINT1 必须作为一种治疗精神疾病的潜在靶点进行更深入的研究。